KR20100097857A - 피부 미백용 화장료 조성물 - Google Patents
피부 미백용 화장료 조성물 Download PDFInfo
- Publication number
- KR20100097857A KR20100097857A KR1020090016714A KR20090016714A KR20100097857A KR 20100097857 A KR20100097857 A KR 20100097857A KR 1020090016714 A KR1020090016714 A KR 1020090016714A KR 20090016714 A KR20090016714 A KR 20090016714A KR 20100097857 A KR20100097857 A KR 20100097857A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- skin
- cosmetic composition
- melanin
- skin whitening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 239000002537 cosmetic Substances 0.000 title claims abstract description 23
- 239000000284 extract Substances 0.000 claims abstract description 59
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 24
- 239000000779 smoke Substances 0.000 claims abstract description 9
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 46
- 241000121220 Tricholoma matsutake Species 0.000 claims description 9
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 244000061176 Nicotiana tabacum Species 0.000 claims description 3
- 229960000271 arbutin Drugs 0.000 claims description 3
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 3
- 229960004705 kojic acid Drugs 0.000 claims description 3
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 3
- -1 licorice extract Chemical compound 0.000 claims description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 3
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229940067599 ascorbyl glucoside Drugs 0.000 claims description 2
- 229940069445 licorice extract Drugs 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 1
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 241000208125 Nicotiana Species 0.000 abstract description 21
- 208000012641 Pigmentation disease Diseases 0.000 abstract description 18
- 230000008099 melanin synthesis Effects 0.000 abstract description 16
- 230000002401 inhibitory effect Effects 0.000 abstract description 8
- 210000003491 skin Anatomy 0.000 description 45
- 210000002752 melanocyte Anatomy 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 14
- 238000000605 extraction Methods 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 11
- 235000011613 Pinus brutia Nutrition 0.000 description 11
- 241000018646 Pinus brutia Species 0.000 description 11
- 230000019612 pigmentation Effects 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 9
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000009472 formulation Methods 0.000 description 5
- 210000002510 keratinocyte Anatomy 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- 240000000233 Melia azedarach Species 0.000 description 4
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 244000252132 Pleurotus eryngii Species 0.000 description 3
- 235000001681 Pleurotus eryngii Nutrition 0.000 description 3
- 235000014443 Pyrus communis Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000003425 Tyrosinase Human genes 0.000 description 3
- 108060008724 Tyrosinase Proteins 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Chemical compound OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 241000158728 Meliaceae Species 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- DNVPQKQSNYMLRS-APGDWVJJSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-APGDWVJJSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- DABHSVCBZNIZDT-WFJMIKGLSA-N (2r,5r)-5-(3,3-dimethyloxiran-2-yl)-3-[(3s,9r,10r,13s,14s,17r)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-17-yl]oxolan-2-ol Chemical compound CC1(C)OC1[C@@H]1O[C@@H](O)C([C@@H]2[C@@]3(CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC=C4[C@@]3(C)CC2)C)C1 DABHSVCBZNIZDT-WFJMIKGLSA-N 0.000 description 1
- ZWXPNDUTGNVQEU-STEPOWRLSA-N (5r,9r,10r,13s,14s,17s)-17-[(2r,3s,5r)-5-[(2s)-3,3-dimethyloxiran-2-yl]-2-hydroxyoxolan-3-yl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one Chemical compound CC1(C)O[C@H]1[C@@H]1O[C@@H](O)[C@H]([C@H]2[C@@]3(CC[C@@H]4[C@@]5(C)CCC(=O)C(C)(C)[C@@H]5CC=C4[C@@]3(C)CC2)C)C1 ZWXPNDUTGNVQEU-STEPOWRLSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- PBFGMXZRJIUGKU-UHFFFAOYSA-N 3-decanoyloxybutyl decanoate Chemical compound CCCCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCCCC PBFGMXZRJIUGKU-UHFFFAOYSA-N 0.000 description 1
- LFESLSYSZQYEIZ-UHFFFAOYSA-N 3-octanoyloxybutyl octanoate Chemical compound CCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCC LFESLSYSZQYEIZ-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 108090000448 Aryl Hydrocarbon Receptors Proteins 0.000 description 1
- 102100026792 Aryl hydrocarbon receptor Human genes 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 240000000724 Berberis vulgaris Species 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 206010004950 Birth mark Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- DABHSVCBZNIZDT-UHFFFAOYSA-N Deacetylturraeanthin Natural products CC1(C)OC1C1OC(O)C(C2C3(CCC4C5(C)CCC(O)C(C)(C)C5CC=C4C3(C)CC2)C)C1 DABHSVCBZNIZDT-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000158723 Melia Species 0.000 description 1
- ZWXPNDUTGNVQEU-UHFFFAOYSA-N Melianon Natural products CC1(C)OC1C1OC(O)C(C2C3(CCC4C5(C)CCC(=O)C(C)(C)C5CC=C4C3(C)CC2)C)C1 ZWXPNDUTGNVQEU-UHFFFAOYSA-N 0.000 description 1
- ZWXPNDUTGNVQEU-CUVMGBAKSA-N Melianone Natural products O=C1C(C)(C)[C@H]2[C@@](C)([C@@H]3C([C@]4(C)[C@](C)([C@H]([C@H]5[C@H](O)O[C@H]([C@H]6C(C)(C)O6)C5)CC4)CC3)=CC2)CC1 ZWXPNDUTGNVQEU-CUVMGBAKSA-N 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940114374 butylene glycol dicaprylate Drugs 0.000 description 1
- 235000013733 carotene rich food Nutrition 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 231100000508 hormonal effect Toxicity 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002780 melanosome Anatomy 0.000 description 1
- DABHSVCBZNIZDT-JJDPDEBESA-N melianol Natural products CC1(C)O[C@H]1[C@H]1C[C@H]([C@H](O)O1)[C@@H]1CC[C@]2(C)C3=CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]12C DABHSVCBZNIZDT-JJDPDEBESA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003254 radicals Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
| 성분명 | 함량 |
| 1. 정제수 | 잔량 |
| 2. 부틸렌글리콜 | 5.0 |
| 3. 베타인 | 2.0 |
| 4. 실시예 1의 고련피 추출물 | 0.5 |
| 5. 실시예 2의 송이 추출물 | 0.5 |
| 6. 세테아릴알코올 세테아릴글루코사이드 | 2.0 |
| 7. 폴리글리세릴모노스테아레이트 | 2.0 |
| 8. 식물성 스쿠알란 | 5.0 |
| 9. 부틸렌글리콜 디카프릴레이트/ 디카프레이트 | 0.5 |
| 10. 디메치콘 | 3.0 |
| 11. 사이클로메치콘 | 5.0 |
| 12. 하이드록시에틸아크릴레이트/ 소듐아크릴로일디메틸타우레이트 코폴리머 | 0.5 |
| 13. 방부제 | 적량 |
| 14. 향 | 적량 |
Claims (5)
- 고련피 추출물 및 송이 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물.
- 제 1항에 있어서, 상기 조성물은 담배 연기로 인한 멜라닌의 생성 증가 억제용임을 특징으로 하는 피부 미백용 화장료 조성물
- 제 1항에 있어서, 상기 조성물은 아스코빌 글루코사이드, 감초추출물, 알부틴, 아스코르브산 및 코지산으로 이루어진 군에서 선택된 1종 이상의 미백 성분을 더 함유하는 것임을 특징으로 하는 미백용 화장료 조성물.
- 제 1항에 있어서, 상기 고련피 추출물은 조성물 총 중량에 대하여 0.001∼5.0 중량%로 함유됨을 특징으로 하는 피부 미백용 화장료 조성물.
- 제 1항에 있어서, 상기 송이 추출물은 조성물 총 중량에 대하여 0.001∼5.0 중량%로 함유됨을 특징으로 하는 피부 미백용 화장료 조성물.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020090016714A KR20100097857A (ko) | 2009-02-27 | 2009-02-27 | 피부 미백용 화장료 조성물 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020090016714A KR20100097857A (ko) | 2009-02-27 | 2009-02-27 | 피부 미백용 화장료 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20100097857A true KR20100097857A (ko) | 2010-09-06 |
Family
ID=43004901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020090016714A Ceased KR20100097857A (ko) | 2009-02-27 | 2009-02-27 | 피부 미백용 화장료 조성물 |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20100097857A (ko) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103131195A (zh) * | 2013-02-04 | 2013-06-05 | 云南茂昽生物科技有限公司 | 一种松茸活性提取物及其制备方法与应用 |
| WO2014208990A1 (ko) * | 2013-06-24 | 2014-12-31 | 주식회사 아모레퍼시픽 | 백화고 유래의 에르고스테롤을 포함하는 피부 외용제 조성물 |
| CN118059010A (zh) * | 2024-02-20 | 2024-05-24 | 植物医生(广东)生物科技有限公司 | 一种含有雪莲花提取物的组合物及其制备方法 |
| CN119837812A (zh) * | 2025-01-15 | 2025-04-18 | 北京植物医生生物科技有限公司 | 抑制抗坏血酸葡糖苷变色的组合物及其在抗氧化护肤品中的应用 |
-
2009
- 2009-02-27 KR KR1020090016714A patent/KR20100097857A/ko not_active Ceased
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103131195A (zh) * | 2013-02-04 | 2013-06-05 | 云南茂昽生物科技有限公司 | 一种松茸活性提取物及其制备方法与应用 |
| WO2014208990A1 (ko) * | 2013-06-24 | 2014-12-31 | 주식회사 아모레퍼시픽 | 백화고 유래의 에르고스테롤을 포함하는 피부 외용제 조성물 |
| US9901525B2 (en) | 2013-06-24 | 2018-02-27 | Amorepacific Corporation | External use skin composition, containing Lentinula edodes-derived ergosterol |
| CN118059010A (zh) * | 2024-02-20 | 2024-05-24 | 植物医生(广东)生物科技有限公司 | 一种含有雪莲花提取物的组合物及其制备方法 |
| CN118059010B (zh) * | 2024-02-20 | 2024-11-26 | 植物医生(广东)生物科技有限公司 | 一种含有雪莲花提取物的组合物及其制备方法 |
| CN119837812A (zh) * | 2025-01-15 | 2025-04-18 | 北京植物医生生物科技有限公司 | 抑制抗坏血酸葡糖苷变色的组合物及其在抗氧化护肤品中的应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111201012A (zh) | 包含积雪草不定根提取物作为有效成分的用于皮肤美白及皱纹改善的化妆品组合物 | |
| KR101387308B1 (ko) | 황칠나무 발효산물을 이용한 피부 미백 화장료 조성물 | |
| KR102253376B1 (ko) | 가는갯능쟁이 추출물 또는 계요등 추출물을 유효성분으로 함유하는 주름 개선 또는 피부 미백용 조성물 | |
| KR102158780B1 (ko) | 천연소재 추출물을 포함하는 피부 개선용 조성물 | |
| KR101921832B1 (ko) | 증삼액을 포함하는 피부 미백용 화장료 조성물 | |
| KR101026879B1 (ko) | 피부주름개선용 화장료 조성물의 제조방법 | |
| KR101711002B1 (ko) | 인삼잎추출물 제조방법 및 이를 유효성분으로 함유하는 화장료 조성물 | |
| KR20080049332A (ko) | 미백용 합마유 추출물 | |
| KR20100097857A (ko) | 피부 미백용 화장료 조성물 | |
| CN106413687B (zh) | 含有红景天提取物和银杏提取物的产品及其制备方法和用途 | |
| KR20100121352A (ko) | 피부노화 예방 및 미용 효과를 지니는 복합생약 조성물 그리고 피부노화 예방 및 개선용 건강 기능 식품 | |
| KR101456059B1 (ko) | 자감초 추출물을 함유하는 피부 미백 및 노화 방지용 화장료 조성물 | |
| CN103796631A (zh) | 含有羟基积雪草苷的皮肤美白组合物 | |
| KR20110109568A (ko) | 맥주 효모를 이용한 미백 화장료 조성물 | |
| KR20090013293A (ko) | 배 추출물을 함유하는 피부노화억제용 주름개선 화장료조성물 | |
| KR20020035656A (ko) | 삼백초추출물로 이루어진 티로시나제 저해제 및 이를함유하는 미백화장료 | |
| KR20170137549A (ko) | 복합 생약 추출물을 포함하는 피부 개선용 조성물 | |
| KR20120036417A (ko) | 참다시마 추출물을 유효성분으로 함유하는 피부 미백용 화장료 조성물 | |
| KR101854766B1 (ko) | 미백 효능을 갖는 트리히드록시 이소플라본 및 감초 추출물의 복합체 | |
| KR101182765B1 (ko) | 항산화 및 항노화 효과를 가지는 산물진피 및 생강 혼합추출물을 포함하는 화장료 조성물 및 그 제조방법 | |
| KR102356144B1 (ko) | 피부 미백 및 주름 개선용 건강기능식품 및 화장료 조성물 | |
| KR102168533B1 (ko) | 한약재 추출물을 포함하는 미백 또는 안색 개선용 화장료 조성물 | |
| KR100500642B1 (ko) | 전호 추출물 또는 정력자 추출물을 함유하는 미백제 | |
| KR102825783B1 (ko) | 천연물유래 추출물을 유효성분으로 포함하는, 미백 및 항산화 활성용 화장료 조성물 | |
| CN109010112B (zh) | 含有作为主要有效成分的人参皂苷y的皮肤外用剂组合物的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20090227 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20140203 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20090227 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20150709 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20160127 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20150709 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |